Meta-analysis: hepatitis B reactivation in patients receiving biological therapy.

Hydar El JamalyGuy D EslickMartin Weltman

Published in: Alimentary pharmacology & therapeutics (2022)

HBVr prevalence rates differ between the chronic carrier state and the occult carrier state. The uptake of prophylactic antiviral therapy in high-risk groups was low, contrary to clinical practice guidelines.

Keyphrases

systematic review
risk factors
meta analyses
randomized controlled trial
mesenchymal stem cells
replacement therapy
chemotherapy induced